Neuroscience News and Research

RSS

Deuterium-containing sigma-1 agonist demonstrates anti-seizure, anti-inflammatory effects in TBI model

Research results published in the Journal of Neurotrauma and conducted by the Walter Reed Army Institute of Research (WRAIR) as part of a collaboration with Concert Pharmaceuticals, Inc. showed that a novel deuterium-containing sigma-1 agonist invented at Concert, called C-10068, demonstrated anti-seizure and anti-inflammatory effects in a preclinical model of traumatic brain injury (TBI).

24 Mar 2015

Discovery can help stop emergence of age-related neurodegenerative diseases

As medicine has improved, increasing our ability to treat disease, so our longevity. The deterioration of the body with age, though, is a whole other matter.

23 Mar 2015

New study pinpoints major increase in subdural hematoma surgery by 2030

By 2030, chronic subdural hemorrhage (SDH) will be the most common adult brain condition requiring neurosurgical intervention in the U.S., according to a new study conducted by researchers at NYU Langone Medical Center.

23 Mar 2015

Researchers examine why joint infections persist despite standards of care

Researchers at Thomas Jefferson University and the National Institutes of Health are building on their research which seeks to understand why joint infections persist despite standards of care designed to stop them.

23 Mar 2015

Olive ingredients may prevent Alzheimer's disease

It has long been proven that people who follow a Mediterranean diet and keep physically and mentally active are less likely to suffer from dementia. Olives in particular appear to play a key role in this regard. But just what are the substances contained in these small, oval fruit that are so valuable? This is what a Hessen-based group of researchers from the Goethe University Frankfurt, the Technical University of Darmstadt and Darmstadt company N-Zyme BioTec GmbH intends to find out. The three-year project "NeurOliv" has a project volume of 1.3 million Euros and is funded by the Federal Ministry of Education and Research as part of the high-tech initiative "KMU-innovativ Biochance".

20 Mar 2015

Study offers new insights into diagnosis and treatment of social dysfunctions

What if there were a pill that made you more compassionate and more likely to give spare change to someone less fortunate? UC Berkeley scientists have taken a big step in that direction.

20 Mar 2015

AbbVie signs exclusive worldwide license agreement with C2N for Alzheimer's disease therapies

AbbVie today announced that it has entered into an exclusive worldwide license agreement with C2N Diagnostics, a privately held protein diagnostic and therapeutic discovery company, to develop and commercialize a portfolio of anti-tau antibodies for the treatment of Alzheimer's Disease and other neurological disorders.

19 Mar 2015

Sigma-Aldrich, Roche sign distribution agreement for Biochemical Reagents products

Sigma-AldrichCorporation, a leading Life Science and Technology company, announced today it signed an exclusive global distribution agreement with Roche. The agreement pairs Roche's high-quality Biochemical Reagents product portfolio with the industry-leading eCommerce and supply chain capabilities of Sigma-Aldrich.

19 Mar 2015

Daiichi Sankyo signs co-commercialization agreement with AstraZeneca for MOVANTIK (naloxegol)

Daiichi Sankyo, Inc. today announced a co-commercialization agreement with AstraZeneca for MOVANTIK (naloxegol) in the US, in line with the Daiichi Sankyo strategy to expand its US portfolio through strategic alliances, in addition to internal R&D and acquisitions.

19 Mar 2015

New scoring system may help predict memory and thinking problems in elderly people

Researchers have developed a new scoring system to help determine which elderly people may be at a higher risk of developing the memory and thinking problems that can lead to dementia, according to a new study published in the March 18, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.

19 Mar 2015

Janssen announces acquisition of XO1

Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that it has acquired XO1 Limited, a privately held asset-centric virtual biopharmaceutical company founded to develop the anti-thrombin antibody ichorcumab.

19 Mar 2015

New tool assesses performance of everyday activities in people with TBI

A recent article by Kessler Foundation researchers describes Actual Reality; as a new tool for assessing performance of activities of everyday life (ADL) in people with traumatic brain injury (TBI). The article, "Actual Reality: Using the Internet to assess everyday functioning after traumatic brain injury," was epublished on February 19 in Brain Injury.

19 Mar 2015

Memorial Hermann Sugar Land Hospital wins Texas Award for Performance Excellence

The Quality Texas Foundation has awarded Memorial Hermann Sugar Land Hospital the Texas Award for Performance Excellence. Memorial Hermann Sugar Land is one of just three organizations in the state to be given this prestigious award recognizing strong dedication to quality and high performance.

18 Mar 2015

UT Southwestern neuroscientists identify key brain cells that control circadian rhythms

UT Southwestern Medical Center neuroscientists have identified key cells within the brain that are critical for determining circadian rhythms, the 24-hour processes that control sleep and wake cycles, as well as other important body functions such as hormone production, metabolism, and blood pressure.

18 Mar 2015

Students attending Brainworks program to learn how regular exercise may help improve brain health

About 140 seventh- and eighth-graders attending Cedars-Sinai's Brainworks program March 23 will learn how hopping, skipping, jumping and other elements of a regular exercise routine may help improve brain health. An exercise station - a new feature of the 17-year-old program - will be one of nine areas where students will interact with Cedars-Sinai neurosurgeons, neurologists, neuroscientists and other health professionals.

18 Mar 2015

Researchers working on new tool for diagnosing concussions in young Canadians

Researchers at the Montreal Neurological Institute and Hospital -The Neuro, at McGill University and the MUHC, are working to develop a much needed tool for helping diagnose concussions or mild traumatic brain injuries suffered by thousands of young Canadians ---hockey and football players among them.

18 Mar 2015

Researchers develop new AFM system for imaging structural dynamics of living cells, neurons

While progress has been made over the past decades in the pursuit to optimize atomic force microscopy (AFM) for imaging living cells, there were still a number of limitations and technological issues that needed to be addressed before fundamental questions in cell biology could be address in living cells.

18 Mar 2015

Janssen Pharmaceutical to invest $10 million in global Dementia Discovery Fund

Johnson & Johnson today announced that its Janssen Pharmaceutical Companies will invest $10 million in a new UK government-led global dementia discovery fund that will support innovative research to help find new ways to prevent and treat dementia and Alzheimer's disease.

17 Mar 2015

Common herpes drug Valacyclovir decreases HIV-1 levels

Case Western Reserve researchers are part of an international team that has discovered that a common herpes drug reduces HIV-1 levels — even when patients do not have herpes.

16 Mar 2015

Max Planck Florida Institute receives NIH grant to study cerebral cortex function and development

Dr. David Fitzpatrick, Scientific Director and CEO at the Max Planck Florida Institute for Neuroscience, has been awarded a $2.4 million five-year grant from the National Eye Institute (NEI) of the National Institutes of Health (NIH) to study the functional organization and development of neural circuits in the cerebral cortex, specifically, in the area of brain responsible for processing visual information.

13 Mar 2015

Neuroscience News and Research

Deuterium-containing sigma-1 agonist demonstrates anti-seizure, anti-inflammatory effects in TBI model

Discovery can help stop emergence of age-related neurodegenerative diseases

New study pinpoints major increase in subdural hematoma surgery by 2030

Researchers examine why joint infections persist despite standards of care

Olive ingredients may prevent Alzheimer's disease

Study offers new insights into diagnosis and treatment of social dysfunctions

AbbVie signs exclusive worldwide license agreement with C2N for Alzheimer's disease therapies

Sigma-Aldrich, Roche sign distribution agreement for Biochemical Reagents products

Daiichi Sankyo signs co-commercialization agreement with AstraZeneca for MOVANTIK (naloxegol)

New scoring system may help predict memory and thinking problems in elderly people

Janssen announces acquisition of XO1

New tool assesses performance of everyday activities in people with TBI

Memorial Hermann Sugar Land Hospital wins Texas Award for Performance Excellence

UT Southwestern neuroscientists identify key brain cells that control circadian rhythms

Students attending Brainworks program to learn how regular exercise may help improve brain health

Researchers working on new tool for diagnosing concussions in young Canadians

Researchers develop new AFM system for imaging structural dynamics of living cells, neurons

Janssen Pharmaceutical to invest $10 million in global Dementia Discovery Fund

Common herpes drug Valacyclovir decreases HIV-1 levels

Max Planck Florida Institute receives NIH grant to study cerebral cortex function and development

Event guide: 2nd Neuroscience Innovation Partnering & Licensing Summit eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News